Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein
- PMID: 3035211
- PMCID: PMC254230
- DOI: 10.1128/JVI.61.7.2100-2108.1987
Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein
Abstract
In this paper we describe the posttranslational processing of the p63/LMP (latent membrane protein) encoded by Epstein-Barr virus in transformed B cells. Specifically, we show that after synthesis, free LMP disappeared with a half-life of about 0.5 h. This was caused by the association of LMP with an insoluble complex. All detectable LMP in the plasma membrane was insoluble. This interaction was resistant to nondenaturing detergents but readily dissociated with 8 M urea or by boiling in 0.5% sodium dodecyl sulfate, suggesting that LMP may be associated with cytoskeletal elements. Most of the Nonidet P-40-insoluble LMP was phosphorylated (ppLMP) primarily on serine but also on threonine residues. No phosphotyrosine was detected. Furthermore, greater than 90% of the ppLMP resided in the Nonidet P-40-insoluble fraction, suggesting a strong correlation between complexing and phosphorylation. Additionally, ppLMP was found to be associated with a 53,000-molecular-weight phosphoprotein (pp53) of unknown origin. Finally, LMP turned over extremely rapidly, with a half-life of about 2 h. Taken together, these properties suggest that although LMP falls broadly within the category of phosphorylated, cytoskeleton-associated oncoproteins, it is nevertheless clearly different from any previously described member of this family.
Similar articles
-
Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1.J Virol. 1993 May;67(5):2637-45. doi: 10.1128/JVI.67.5.2637-2645.1993. J Virol. 1993. PMID: 8386269 Free PMC article.
-
Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP.J Virol. 1990 Feb;64(2):829-37. doi: 10.1128/JVI.64.2.829-837.1990. J Virol. 1990. PMID: 2153246 Free PMC article.
-
Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.J Gen Virol. 1987 Jun;68 ( Pt 6):1575-86. doi: 10.1099/0022-1317-68-6-1575. J Gen Virol. 1987. PMID: 2438376
-
Detection by monoclonal antibodies of an early membrane protein induced by Epstein-Barr virus.J Virol. 1986 Nov;60(2):369-75. doi: 10.1128/JVI.60.2.369-375.1986. J Virol. 1986. PMID: 3021971 Free PMC article.
-
Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.Mod Pathol. 1994 May;7(4):454-61. Mod Pathol. 1994. PMID: 7520586 Review.
Cited by
-
Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1.J Virol. 1993 May;67(5):2637-45. doi: 10.1128/JVI.67.5.2637-2645.1993. J Virol. 1993. PMID: 8386269 Free PMC article.
-
The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.J Virol. 1999 Dec;73(12):9908-16. doi: 10.1128/JVI.73.12.9908-9916.1999. J Virol. 1999. PMID: 10559303 Free PMC article.
-
Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Mol Cell Biol. 2002 Apr;22(7):2136-46. doi: 10.1128/MCB.22.7.2136-2146.2002. Mol Cell Biol. 2002. PMID: 11884601 Free PMC article.
-
Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.Oncogene. 1999 Nov 22;18(49):6959-64. doi: 10.1038/sj.onc.1203217. Oncogene. 1999. PMID: 10602470 Review.
-
Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells.J Virol. 1992 Jul;66(7):4612-6. doi: 10.1128/JVI.66.7.4612-4616.1992. J Virol. 1992. PMID: 1318423 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources